Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The retinoid-dependent intracellular signaling pathway refers to a set of mechanisms in which retinoids (oxidized derivatives of vitamin A, such as all-trans retinoic acid) bind to nuclear receptors called retinoic acid receptor (RAR) and retinoid X receptor (RXR). Upon ligand binding, these receptors form heterodimers, translocate to the nucleus, and bind to specific DNA sequences called retinoic acid response elements (RAREs). This leads to the activation or repression of target genes controlling cellular differentiation, proliferation, and organogenesis. Non-canonical retinoid signaling can also involve rapid kinase-mediated signaling cascades and intercellular communication. Defects or manipulations of these receptors are implicated in a variety of diseases, especially developmental disorders and cancer[1][2][3][4][5][6][7].
Agonism of RAR or RXR to induce or repress gene transcription by binding to retinoic acid response elements (RARE) in DNA[2][3][4][5][7] Modulation of cell differentiation and proliferation via altered transcriptional programs
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid receptor (RAR) and Retinoid X receptor (RXR) (RAR, RXR).